ArticleHealth science reports2026
Trends in Meningitis Burden and Projections to 2040: A Secondary Analysis of the Global Burden of Disease Study 2023.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends in Meningitis Burden and Projections to 2040: A Secondary Analysis of the Global Burden of Disease Study 2023.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Meningitis remains a global health challenge, characterized by substantial regional and etiologic disparities. This study aimed to analyze recent trends, forecast future burden, and examine the influence of development status on meningitis outcomes. Methods: We used Global Burden of Disease 2023 data to assess trends in age-standardized incidence rate (ASIR), age-standardized disability-adjusted life-year (DALY) rate (ASDR), and age-standardized mortality rate (ASMR) for meningitis from 1990 to 2023 across regions and major etiologies. Temporal trends were assessed using joinpoint regression. Future projections through 2040 were generated using a hybrid time-series model. Development-related disparities were explored using multilevel regression based on the Human Development Index (HDI), and spatial clustering was analyzed. Results: From 1990 to 2023, global meningitis burden declined markedly, with ASIR, ASDR, and ASMR decreasing by roughly half. Despite these improvements, Sub-Saharan Africa remained the most affected region in 2023, showing the highest ASIR, ASDR, and ASMR and the smallest proportional declines. Etiology-specific analyses demonstrated substantial heterogeneity. Among bacterial causes, Conclusion: Despite substantial global declines, meningitis remains unevenly distributed, especially in Sub-Saharan Africa, where incidence, DALY burden, and mortality remain highest. Projections show continued improvement, although
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.